Rémi Quirion, OC, PhD, FRSC, CQ, is the inaugural Chief Scientist of Quebec since July 1st, 2011. A McGill Full Professor, Psychiatry and Scientific Director at the Douglas Mental Health University Institute. He served as Vice-Dean, Faculty of Medicine at McGill University, as well as Senior University Advisor (Health Sciences Research) in addition to being the CIHR Executive Director, for Alzheimer’s Diseases, from 2009 to 2011.
Since the beginning of his tenure at the Douglas Institute Research Centre in 1983, Rémi Quirion, has cultivated a diverse laboratory and trained over 70 students and fellows, from all over the world, dedicated to the study of brain peptides (neuropeptide Y, CGRP), growth factors (nerve growth factor and insulin-like growth factor-1), and the role of programmed cell death in the pathogenesis of Alzheimer Disease and other neurodegenerative diseases.
In addition to being scientific director of the Douglas Institute Research Centre from 1996 to 2011, Rémi Quirion was the Inaugural Scientific Director of the Institute of Neurosciences, Mental Health and Addiction, one of the thirteen Canadian Institutes of Health Research (CIHR).
Work from Rémi Quirion’s lab has helped to characterize the roles of cholinergic synapses in Alzheimer Disease, neuropeptide Y in depression and learning, and calcitonin gene-related peptide (CGRP) in pain and opioid tolerance.
Rémi Quirion left the Douglas institute in 2011 to become Quebec’s first Chief Scientist.